Abcam, ab300088, Anti-Tetanus toxoid antibody [35F7] - BSA and Azide free

Size: 100µg / 1mg
Mouse Recombinant Monoclonal TETX antibody. Carrier free. Suitable for WB, I-ELISA and reacts with Transfected cell lysate - Clostridium tetani, Clostridium tetani samples.
Key facts
Host species:Mouse,
Clonality:Monoclonal,
Clone number:35F7,
Isotype:IgG1,
Carrier free:Yes,
Reacts with:Clostridium tetani,
Applications:WB, I-ELISASee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Product details:
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our
conjugation kits
for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Compatibility
This product is compatible with the Maxpar
Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar
is a trademark of Fluidigm Canada Inc.

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.2 - 7.4Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C, Storage information-Do Not Freeze

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Tetanus Toxoid often referred to as TT is an inactivated toxin used in vaccines to prevent tetanus. It originates from the bacterium Clostridium tetani which produces the neurotoxin tetanospasmin. This toxoid has a mass of approximately 150 kDa and is conventionally administered as a vaccine in humans and animals. It triggers an immune response without causing disease as it's a detoxified version of the toxin. Tetanus toxoid is expressed in a laboratory setting where it undergoes chemical treatment to eliminate toxicity while maintaining its antigenicity.
Biological function summary
Tetanus toxoid stimulates the immune system to produce antibodies against the active tetanus toxin tetanospasmin. It doesn't form part of any specific protein complexes but functions independently to evoke humoral immunity. The binding of these antibodies to tetanospasmin neutralizes its effect thereby preventing the inhibition of neurotransmitter release. This process is important for avoiding the spasms and muscle rigidity associated with tetanus. The immune response it provokes includes the activation of B cells which differentiate into plasma cells that produce anti-tetanus antibodies.
Pathways
Tetanus toxoid plays an integral part in the adaptive immune response. It functions within the humoral immune pathway by stimulating the Th2 response. This activation is associated with B-cell proliferation and differentiation into antibody-secreting cells which provide long-term immunity. The vaccine-related immune response connects to key immunological proteins like CD4+ T-helper cells which play a central role in modulating the immune system's response to vaccines.
The tetanus toxoid vaccine is directly related to preventing tetanus an acute often fatal infection marked by severe muscle contractions. By inducing immunity tetanus toxoid plays a preventive role against tetanospasmin-mediated dysfunction in the nervous system. Additionally the concept of herd immunity associated with tetanus prevention helps in protecting community members including those unvaccinated. No other direct protein associations in disorders are typically highlighted but successful immunization inherently aids in broader public health by reducing incidences of infection.